$8.37
+0.10 (+1.21%)
Open$7.92
Previous Close$8.27
Day High$8.40
Day Low$7.91
52W High$14.21
52W Low$2.85
Volume—
Avg Volume14.4K
Market Cap76.84M
P/E Ratio—
EPS$-20.70
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+380.5% upside
Current
$8.37
$8.37
Target
$40.22
$40.22
$30.63
$40.22 avg
$46.08
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 9.05M | 8.81M | 7.55M |
| Net Income | 1.50M | 1.95M | 1.65M |
| Profit Margin | 16.6% | 22.2% | 21.9% |
| EBITDA | 2.36M | 2.47M | 1.95M |
| Free Cash Flow | 1.28M | 1.29M | 705.7K |
| Rev Growth | -8.9% | +8.5% | +16.9% |
| Debt/Equity | 0.33 | 0.32 | 0.30 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |